Overexpression of Runx2 directed by the matrix metalloproteinase‐13 promoter containing the AP‐1 and Runx/RD/Cbfa sites alters bone remodeling in vivo
The DOI matches its Crossref record.
Abstract
The activator protein‐1 (AP‐1) and runt domain binding (Runx/RD/Cbfa) sites and their respective binding proteins, c‐Fos/c‐Jun and Runx2 (Cbfa1), regulate the rat matrix metalloproteinase‐13 (MMP‐13) promoter in both parathyroid hormone (PTH)‐treated and differentiating osteoblastic cells in culture. To determine the importance of these regulatory sites in the expression of MMP‐13 in vivo, transgenic mice containing either wild‐type (−456 or −148) or AP‐1 and Runx/RD/Cbfa sites mutated (−148A 3 R 3) MMP‐13 promoters fused with the E. coli lacZ reporter were generated. The wild‐type transgenic lines expressed higher levels of bacterial β‐galactosidase in bone, teeth, and skin compared to the mutant and non‐transgenic lines. Next, we investigated if overexpression of Runx2 directed by the MMP‐13 promoter regulated expression of bone specific genes in vivo, and whether this causes morphological changes in these animals. Real time RT‐PCR experiments identified increased mRNA expression of bone forming genes and decreased MMP‐13 in the tibiae of transgenic mice (14 days and 6 weeks old). Histomorphometric analyses of the proximal tibiae showed increased bone mineralization surface, mineral apposition rate, and bone formation rate in the transgenic mice which appears to be due to decreased osteoclast number. Since MMP‐13 is likely to play a role in recruiting osteoclasts to the bone surface, decreased expression of MMP‐13 may cause reduced osteoclast‐mediated bone resorption, resulting in greater bone formation in transgenic mice. In summary, we show here that the 148 bp upstream of the MMP‐13 transcriptional start site is sufficient and necessary for gene expression in bone, teeth, and skin in vivo and the AP‐1 and Runx/RD/Cbfa sites are likely to regulate this. Overexpression of Runx2 by these regulatory elements appears to alter the balance between the bone formation‐bone resorption processes in vivo. J. Cell. Biochem. 99: 545–557, 2006. © 2006 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The regulation of matrix metalloproteinases and their inhibitors
Clark, I. M., Swingler, T. E., Sampieri, C. L., & Edwards, D. R. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.12.006 · Cited by 555
Transcriptional Regulatory Cascades in Runx2-Dependent Bone Development
Liu, T. M., & Lee, E. H. (2013) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2012.0527 · Cited by 375
Akech, J., Wixted, J. J., Bedard, K., van der Deen, M., Hussain, S., Guise, T. A., van Wijnen, A. J., Stein, J. L., Languino, L. R., Altieri, D. C., et al. (2010) · Oncogene · doi:10.1038/onc.2009.389 · Cited by 295
Regulation of gene expression in osteoblasts
Jensen, E. D., Gopalakrishnan, R., & Westendorf, J. J. (2010) · BioFactors · doi:10.1002/biof.72 · Cited by 226
“PTH also regulates Runx2 activity through other mechanisms such as phosphorylation [35] and promoting interactions with AP-1 transcription factors [36,37].”
BackgroundBehonick, D. J., Xing, Z., Lieu, S., Buckley, J. M., Lotz, J. C., Marcucio, R. S., Werb, Z., Miclau, T., & Colnot, C. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001150 · Cited by 189
Metadata
- Authors
- Selvamurugan, N., Jefcoat, S. C., Kwok, S., Kowalewski, R., Tamasi, J. A., & Partridge, N. C.
- Venue
- Journal of Cellular Biochemistry
- Publisher
- Wiley
- Published
- 2006-04-25
- Volume
- 99
- Issue
- 2
- Pages
- 545-557
- ISSN
- 0730-2312 (ISSN-L)
- 1097-4644
- OpenAlex
- W1973917015
- Cited by
- 63
- References
- 0
- FWCI
- 1.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.